Blog

Dark Side of ATP

Posted: 1/5/2007

New Study Uncovers the Dark Side of ATP

Researchers have found that one of the most common and hard-working substances in the body may have a Jekyll and Hyde quality in rosacea patients, assuming a darker role when activated by flare-up triggers.



New Drug Introduced

Posted: 7/25/2006

The following announcement was issued by CollaGenex Pharmaceuticals:

FIRST ORAL DRUG FOR ROSACEA
COLLAGENEX PHARMACEUTICALS
INTRODUCES ORACEA™

(doxycycline, USP) capsules 40 mg*
* 30 mg immediate release and 10 mg delayed release beads



Dry Eye Awareness

Posted: 7/7/2006

The following announcement was issued by the National Women's Health Resource Center:

Do You Live in a Dry Eye Hot Spot?



Trail of Tears May Lead Scientists To First Diagnostic Test for Rosacea

Posted: 6/14/2006

BARRINGTON, Illinois (June 14, 2006) -- A trail of tears may lead to the first diagnostic test for ocular rosacea, a common and potentially serious condition that may result in reduction of vision if left untreated. In a study of human tears funded by the National Rosacea Society (NRS) and published in Rosacea Review, medical scientists have discovered new clues to identify the eye effects of rosacea, a red-faced, acne-like disorder now estimated to affect 14 million Americans.



Summer Rosacea Review

Posted: 6/6/2006

The summer 2006 issue of Rosacea Review is now available on rosacea.org.



Facial Discomfort Survey Results

Posted: 2/20/2006

Survey Shows Facial Disorder Hurts More Than Appearance

BARRINGTON, Illinois (February 20, 2006) -- While the often-devastating impact of rosacea on facial appearance is well recognized, a new survey shows that physical discomfort is also experienced by the majority of people with this red-faced, acne-like disorder now estimated to affect more than 14 million Americans.



New Research Grants Awarded to Further Knowledge of Rosacea

Posted: 1/11/2006

The National Rosacea Society (NRS) announced that five new studies have been awarded funding as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this chronic and potentially devastating disorder that affects an estimated 14 million Americans.